<DOC>
	<DOCNO>NCT02715596</DOCNO>
	<brief_summary>This study design evaluate effect EPA supplementation muscle mass patient squamous cell carcinoma head neck locally advance ( stage III-IVb ) ass supplementation EPA maintain muscle mass along oncologic treatment . Other aims evaluate nutritional status , acute chronic toxicity relate loss muscle mass impact EPA supplementation overall disease-free survival .</brief_summary>
	<brief_title>Changes Body Composition After EPA Supplementation Head Neck Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Age 18 75 year inclusive . A performance status 01 accord ECOG ( Eastern Cooperative Oncology Group ) scale time inclusion study . Expectancy great 3 month life . Location : oral cavity , oropharynx , larynx , hypopharynx , nasopharynx sinus . Patients squamous cell carcinoma head neck classify locally advanced ( Stage III , IVaIVb ) . Patients medical condition receive neoadjuvant chemotherapy ( CT ) induction follow radiotherapy ( RDT ) normo fraction combine QT biological . Neutrophil ≥1500 / mm3 , platelet count ≥150,000 / mm3 hemoglobin ≥10g / dL . Adequate liver function : total bilirubin ≤ 1 x ULN ; aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) ≤ 2.5 x ULN ; Alkaline phosphatase ( ALP ) ≤ 5 x ULN . Serum albuminadjusted calcium ≤ 1.25 x upper limit normal ( ULN ) . Using effective contraceptive method patient sex risk conception / pregnancy . Signature write informed consent studyspecific procedures Metastatic disease ( stage IVc ) . Surgery , radiotherapy / chemotherapy prior study disease treatment . T3 N01 larynx . Other stadium III IV without distant metastasis stable disease . Another synchronous squamous carcinoma . Diagnosis malignancy within past 5 year , except situ cervix / adequately treat basal cell carcinoma skin cancer . Active infection ( infection require intravenous antibiotic ) , include active tuberculosis HIV diagnose . Uncontrolled hypertension define systolic blood pressure ≥180mm Hg / diastolic blood pressure≥ 130 mm Hg rest . Pregnancy ( absence must confirm βHCG ( Human chorionic gonadotropin ) serum test ) lactating . Systemic , chronic immune concomitant treatment , hormonal treatment cancer . Other concomitant antineoplastic treatment . Clinically significant coronary artery history myocardial infarction last 12 month high risk uncontrolled arrhythmia uncontrolled heart failure . Chronic obstructive pulmonary disease would require ≥3 hospitalization last 12 month . Uncontrolled active peptic ulcer . Presence psychological medical illness prevent study patient grant signature inform consent . Abuse know drug ( exception heavy drinking ) . Allergic reaction know component study treatment . Previous treatment monoclonal antibody inhibitor signal transduction treatment direct EGFR ( epidermal growth factor receptor ) . Any experimental therapy within 30 day prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>head neck</keyword>
	<keyword>eicosapentanoic acid</keyword>
	<keyword>body composition</keyword>
</DOC>